Dr. Mathews is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Women and Infants Hospital
101 Dudley St.
Providence, RI 02905Phone+1 401-453-7520
Education & Training
University of Oklahoma Health Sciences CenterFellowship, Gynecologic Oncology, 2009 - 2012
Women and Infants Hospital of Rhode Island/Brown UniversityResidency, Obstetrics and Gynecology, 2005 - 2009
Geisel School of Medicine at DartmouthClass of 2005
Certifications & Licensure
RI State Medical License 2005 - 2026
CT State Medical License 2012 - 2025
MA State Medical License 2012 - 2025
OK State Medical License 2009 - 2015- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2009 Oct 28
- Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer Start of enrollment: 2011 Mar 14
- Chemoradiation Therapy and Ipilimumab in Treating Patients With Stages IB2-IIB or IIIB-IVA Cervical Cancer Start of enrollment: 2012 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 189 citationsRandomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology StudyDmitriy Zamarin, Robert A. Burger, Michael W. Sill, Daniel J. Powell, Heather A. Lankes
Journal of Clinical Oncology. 2020-04-10 - 165 citationsOverall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial.Paul DiSilvestro, Susana Banerjee, Nicoletta Colombo, Giovanni Scambia, Byoung-Gie Kim
Journal of Clinical Oncology. 2023-01-20 - 1656 citationsMaintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian CancerKathleen N. Moore, Nicoletta Colombo, Giovanni Scambia, Byoung Gie Kim, Ana Oaknin
The New England Journal of Medicine. 2018-10-21
Press Mentions
Local Research Contributes to National Standard-of-Care Guidelines for Endometrial CancerApril 24th, 2023- The Power of Shared Purpose: Transforming Gynecologic Cancer CareMarch 26th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
